华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301408 华人健康

已收盘 12-16 15:00:00

{"stockData":{"symbol":"301408","market":"SZ","secType":"STK","nameCN":"华人健康","latestPrice":16.09,"timestamp":1765868628000,"preClose":14.94,"halted":0,"volume":37613385,"delay":0,"changeRate":0.077,"floatShares":149000000,"shares":400000000,"eps":0.4663,"marketStatus":"已收盘","change":1.15,"latestTime":"12-16 15:00:00","open":14.94,"high":16.5,"low":14.51,"amount":587000000,"amplitude":0.1332,"askPrice":16.1,"askSize":521,"bidPrice":16.09,"bidSize":890,"shortable":0,"etf":0,"ttmEps":0.4663,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":14.94,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":16.43,"lowLimit":13.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400010000,"isCdr":false,"pbRate":2.85,"roa":"--","peRate":34.505683,"roe":"7.62%","epsLYR":0.34,"committee":0.276677,"marketValue":6436000000,"turnoverRate":0.2521,"status":0,"floatMarketCap":2400000000},"requestUrl":"/m/hq/s/301408/tweets","defaultTab":"tweets","newsList":[{"id":"2590334640","title":"华人健康：2025年前三季度净利同比增长45.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590334640","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590334640?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:51","pubTimestamp":1765284676,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康12月08日在投资者关系平台上答复投资者关心的问题。公司已于2025年10月25日在巨潮资讯网披露了《2025年第三季度报告》。根据报告，2025年1-9月，公司实现营业收入38.92亿元，同比增长19.06%；归母净利润为1.57亿元，同比增长45.21%。得益于公司在并购整合和提升盈利方面取得积极成效，2025年前三季度净利润增长率显著高于营业收入增长率。未来，公司将继续优化经营策略，提升盈利能力和创造长期价值，为股东带来更好的回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900037412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2589356359","title":"华人健康（301408）披露全资子公司收到药品注册受理通知书，12月08日股价下跌2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589356359","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589356359?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:19","pubTimestamp":1765203581,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，华人健康报收于16.25元，较前一交易日下跌2.93%，最新总市值为65亿元。该股当日开盘16.91元，最高16.97元，最低16.22元，成交额达4.45亿元，换手率为18.2%。公司近日发布公告称，其全资子公司江苏神华药业有限公司收到国家药品监督管理局下发的乳果糖口服溶液药品注册上市许可申请《受理通知书》，受理号为CYHS250***8，规格为15ml:10g。本次注册申请已进入审评阶段，审批结果及后续销售情况存在不确定性，对公司短期业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800034901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2589338083","title":"华人健康(301408.SZ)：乳果糖口服溶液药品注册上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2589338083","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589338083?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:26","pubTimestamp":1765182411,"startTime":"0","endTime":"0","summary":"华人健康(301408.SZ)公告，公司全资子公司江苏神华药业有限公司收到国家药品监督管理局下发的乳果糖口服溶液药品注册上市许可申请《受理通知书》。乳果糖口服溶液是一种缓泻药，是治疗便秘的常用药，具有软化大便和调节肠道规律的作用，主要特点是通便起效快、温和有效，安全性高，适合长期慢性或习惯性便秘人群使用。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2589674338","title":"华人健康：阿里健康为公司前十大股东之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2589674338","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589674338?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:12","pubTimestamp":1765181530,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康12月08日在投资者关系平台上答复投资者关心的问题。阿里健康科技（中国）有限公司是公司于2018年5月引进的战略投资者。根据中国证券登记结算有限责任公司数据，截至2025年9月30日，阿里健康为公司前十大股东之一。公司与阿里健康及其关联服务平台，如支付宝、天猫、饿了么等平台公司均有合作。有关公司经营情况，均以公司在巨潮资讯网披露的公告内容为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800015167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1617","BK1589","BK1584","BK1142","301408","BK1189","BK1247","BK1502","BK1515","BK1615","BK0209","BK1610","BK1571","BK1591","BK1501","00241"],"gpt_icon":0},{"id":"2589338599","title":"华人健康：流感类药品销售量有所上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2589338599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589338599?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:06","pubTimestamp":1765181171,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康12月08日在投资者关系平台上答复投资者关心的问题。根据中国疾病预防控制中心日前发布监测情况显示，全国门急诊流感样病例中流感阳性率已经接近45%，全国流感活动整体进入中流行水平，部分省份已达高流行水平。公司相应地区门店的流感类药品销售量有所上升，上述药品销售预计不会对公司业绩产生重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800014502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2588098540","title":"华人健康：公司股价受多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2588098540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588098540?lang=zh_cn&edition=full","pubTime":"2025-12-03 09:01","pubTimestamp":1764723676,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康12月02日在投资者关系平台上答复投资者关心的问题。感谢您对公司的关注与支持。公司股价的表现受多种因素影响，包括宏观经济环境、行业政策变化、市场情绪波动以及投资者对整体市场的预期等。公司管理层高度重视市值管理，同时也深知良好的业绩是提升市值的核心驱动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300004522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2586230009","title":"11月26日华人健康（301408）龙虎榜数据：游资上海超短帮上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2586230009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586230009?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:49","pubTimestamp":1764150598,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月26日公布的交易公开信息显示，华人健康因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月26日收盘，华人健康报收于17.4元，上涨20.0%，涨停，换手率23.16%，成交量34.55万手，成交额5.7亿元。上海超短帮等知名游资榜上有名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2586286035","title":"异动快报：华人健康（301408）11月26日9点51分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2586286035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586286035?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:55","pubTimestamp":1764122129,"startTime":"0","endTime":"0","summary":"证券之星11月26日盘中消息，9点51分华人健康触及涨停板。其所属行业医药商业目前上涨。该股为医药商业，医药，中药概念热股，当日医药商业概念上涨2.14%，医药概念上涨1.95%，中药概念上涨1.8%。11月25日的资金流向数据方面，主力资金净流入332.7万元，占总成交额1.35%，游资资金净流出632.32万元，占总成交额2.57%，散户资金净流入299.62万元，占总成交额1.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600006933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2582372281","title":"华人健康（301408）披露更换持续督导保荐代表人公告，11月12日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582372281","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582372281?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:08","pubTimestamp":1762956506,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，华人健康报收于15.67元，较前一交易日下跌2.31%，最新总市值为62.68亿元。近日，安徽华人健康医药股份有限公司发布公告，因原持续督导保荐代表人孟超先生工作变动，无法继续履行职责，华泰联合证券决定委派张晨曦先生接替其职务。本次更换后，公司持续督导保荐代表人为范杰先生和张晨曦先生，持续督导期至2026年12月31日。公司董事会对孟超先生在持续督导期间的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2581889158","title":"华人健康：深耕安徽聚焦华东辐射周边","url":"https://stock-news.laohu8.com/highlight/detail?id=2581889158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581889158?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:52","pubTimestamp":1762519959,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康11月06日在投资者关系平台上答复投资者关心的问题。在医药零售业务板块，公司秉持“深耕安徽、聚焦华东、辐射周边”的发展战略，以安徽为核心市场，成功布局江苏、浙江、福建等华东地区，并已成长为区域内具有影响力的医药连锁企业。同时，公司也将持续关注两岸市场的发展动态，把握潜在机遇，推动公司在医药健康领域的长期稳健发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700036609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2578663936","title":"股市必读：华人健康(301408)股东户数2.01万户，较上期减少22.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578663936","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578663936?lang=zh_cn&edition=full","pubTime":"2025-10-27 06:46","pubTimestamp":1761518774,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，华人健康报收于13.17元，上涨0.46%，换手率2.99%，成交量4.45万手，成交额5844.21万元。来自公司公告汇总：华人健康使用自有资金支付募投项目部分款项，并已完成347.74万元的等额置换，保荐机构对此无异议。股本股东变化股东户数变动截至2025年9月30日，华人健康股东户数为2.01万户，较6月30日减少5957.0户，减幅为22.86%。户均持股数量由上期的1.54万股增至1.99万股，户均持股市值为25.2万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2577510958","title":"华人健康（301408）披露使用自有资金支付募投项目部分款项并以募集资金等额置换的公告，10月24日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577510958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577510958?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:39","pubTimestamp":1761316754,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，华人健康报收于13.17元，较前一交易日上涨0.46%，最新总市值为52.68亿元。该股当日开盘13.1元，最高13.2元，最低13.02元，成交额达5844.21万元，换手率为2.99%。近日，华人健康发布公告称，公司使用自有资金支付募投项目部分款项，并以募集资金等额置换。自2025年5月1日至9月30日，累计置换金额为347.74万元，均在自筹资金支付后六个月内完成置换。公司已建立明细台账，按月汇总并履行审批程序，确保专款专用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400043074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2577002511","title":"华人健康(301408.SZ)发布前三季度业绩，归母净利润1.57亿元，增长45.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577002511","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577002511?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:27","pubTimestamp":1761312455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华人健康(301408.SZ)发布2025年三季度报告，该公司前三季度营业收入为38.92亿元，同比增长19.06%。归属于上市公司股东的净利润为1.57亿元，同比增长45.21%。归属于上市公司股东的扣除非经常性损益的净利润为1.51亿元，同比增长51.00%。基本每股收益为0.3918元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华人健康(301408.SZ)发布前三季度业绩，归母净利润1.57亿元，增长45.21%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301408"],"gpt_icon":0},{"id":"2577453195","title":"股市必读：华人健康（301408）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577453195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577453195?lang=zh_cn&edition=full","pubTime":"2025-10-24 04:50","pubTimestamp":1761252615,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，华人健康报收于13.11元，上涨0.15%，换手率2.16%，成交量3.22万手，成交额4198.77万元。董秘最新回复投资者： 董秘，你好！未来，公司将继续探索人工智能技术在医药健康领域的更多创新应用，构建以用户为中心的健康服务新生态，推动医药服务的数字化转型与数智化服务升级。上述药品销售预计不会对公司业绩产生重大影响。当日关注点来自交易信息汇总：10月23日主力资金净流出224.41万元，显示主力短期减持动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2577372378","title":"华人健康：经营奥司他韦等抗流感药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2577372378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577372378?lang=zh_cn&edition=full","pubTime":"2025-10-23 15:04","pubTimestamp":1761203053,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康10月23日在投资者关系平台上答复投资者关心的问题。公司或子公司有没有生产或销售流感药物？公司主要经营和销售包括中西成药、中药饮片、保健食品、医疗器械等产品，产品涵盖抗菌消炎、清热解毒、止咳祛痰平喘、胃肠道、抗感冒、维生素与矿物质、心脑血管、补益中成药、美容保健等类别。上述药品销售预计不会对公司业绩产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300017449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301408","BK0209"],"gpt_icon":0},{"id":"2577860534","title":"股市必读：华人健康（301408）10月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577860534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577860534?lang=zh_cn&edition=full","pubTime":"2025-10-21 02:58","pubTimestamp":1760986691,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，华人健康报收于12.93元，上涨1.89%，换手率2.13%，成交量3.17万手，成交额4087.48万元。董秘最新回复投资者： 业绩年年好，股价年年低，贵司是否有什么解决方案？公司股价受宏观经济、行业政策、市场情绪、资金流向等多种因素综合影响。公司董事会和管理层始终关注公司市值表现，同时也深知良好的业绩是提升市值的关键因素。当日关注点来自交易信息汇总：10月20日主力资金净流入47.05万元，显示主力小幅加仓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100002200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2576881820","title":"华人健康：持续加强市值管理与投资者沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2576881820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576881820?lang=zh_cn&edition=full","pubTime":"2025-10-20 11:33","pubTimestamp":1760931190,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康10月20日在投资者关系平台上答复投资者关心的问题。公司股价受宏观经济、行业政策、市场情绪、资金流向等多种因素综合影响。四是加强投资者沟通交流，通过业绩说明会、投资者调研等多种形式，主动加强与市场沟通，确保投资者充分理解公司的战略规划和经营策略，增进投资者对公司的了解和认同。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000010644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2566626746","title":"华人健康：公司已有40余个在研项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2566626746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566626746?lang=zh_cn&edition=full","pubTime":"2025-09-10 11:36","pubTimestamp":1757475371,"startTime":"0","endTime":"0","summary":"证券之星消息，华人健康09月09日在投资者关系平台上答复投资者关心的问题。公司专注于医药健康产业，致力于为客户提供高品质的医药健康服务。目前，公司已布局医药零售、代理、终端集采及医药研发与生产等业务领域。在医药研发板块，公司从化学仿制药和中药同名同方两个方向，通过自研或与其他机构合作的方式，目前已有40余个在研项目。感谢您对公司的关注与建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000014933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2564803412","title":"华人健康最新公告：全资子公司收到富马酸伏诺拉生片药品注册受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2564803412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564803412?lang=zh_cn&edition=full","pubTime":"2025-09-02 18:01","pubTimestamp":1756807291,"startTime":"0","endTime":"0","summary":"华人健康(301408.SZ)公告称，公司全资子公司江苏神华药业有限公司收到国家药品监督管理局下发的富马酸伏诺拉生片药品注册上市许可申请《受理通知书》。该药品是一种新型的钾离子竞争性酸阻滞剂，用于治疗反流性食管炎及与适当的抗生素联用以根除幽门螺杆菌。受理通知书的获得表示该品种进入注册审评阶段，但完成时间、审批结果及药品获批后的具体销售情况等均具有不确定性，对公司短期业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200029925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","301408"],"gpt_icon":0},{"id":"2564898520","title":"华人健康：公司更倾向于稳健的整合策略 而非大规模扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=2564898520","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564898520?lang=zh_cn&edition=full","pubTime":"2025-09-01 12:20","pubTimestamp":1756700459,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301408","BK0209"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765930194559,"stockEarnings":[{"period":"1week","weight":0.0347},{"period":"1month","weight":-0.0201},{"period":"3month","weight":0.1892},{"period":"6month","weight":0.3927},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.471}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华人健康医药股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"20098人(较上一季度减少22.86%)","perCapita":"7422股","listingDate":"2023-03-01","address":"安徽省合肥市包河区河北路123号","registeredCapital":"40001万元","survey":"　　安徽华人健康医药股份有限公司的主营业务是集医药零售、医药代理、研发生产及终端集采于一体的全产业链。公司的主要产品是中西成药、中药饮片、保健品、医疗器械、特色原料药。","listedPrice":16.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华人健康,301408,华人健康股票,华人健康股票老虎,华人健康股票老虎国际,华人健康行情,华人健康股票行情,华人健康股价,华人健康股市,华人健康股票价格,华人健康股票交易,华人健康股票购买,华人健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华人健康(301408)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华人健康(301408)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}